Prediction of risk of diabetic retinopathy for all-cause mortality, stroke and heart failure Evidence from epidemiological observational studies

被引:5
作者
Zhu, Xiao-Rong [1 ]
Zhang, Yong-Peng [2 ]
Bai, Lu [3 ]
Zhang, Xue-Lian [1 ]
Zhou, Jian-Bo [1 ]
Yang, Jin-Kui [1 ,4 ]
机构
[1] Capital Med Univ, Beijing Tongren Hosp, Dept Endocrinol, Beijing, Peoples R China
[2] Capital Med Univ, Beijing Tongren Hosp, Dept Ophthalmol, Beijing, Peoples R China
[3] Beijing Haidian Hosp, Dept Geratol, Beijing, Peoples R China
[4] Beijing Key Lab Diabet Res & Care, Beijing, Peoples R China
基金
美国国家科学基金会;
关键词
all-cause mortality; diabetic retinopathy; heart failure; stroke; CARDIOVASCULAR-DISEASE; TYPE-1; DYSFUNCTION; ARTERY; COMPLICATIONS; ANGIOGENESIS; METAANALYSIS; ASSOCIATION; NIDDM; OSAKA;
D O I
10.1097/MD.0000000000005894
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To examine and quantify the potential relation between diabetic retinopathy (DR) and risk of all-cause mortality, stroke and heart failure (HF). The resources of meta-analysis of epidemiological observational studies were from Pub-med, EMBASE, CINAHL, Cochrane Library, conference, and proceedings. Random/fixed effects models were used to calculate pooled subgroup analysis stratified by different grades of DR was performed to explore the potential source of heterogeneity. Statistical manipulations were undertaken using program STATA. Of the included 25 studies, comprising 142,625 participants, 19 studies were concluded to find the relation of DR to all-cause mortality, 5 for stroke, and 3 for HF. Risk ratio (RR) for all-cause mortality with the presence of DR was 2.33 (95% CI 1.92-2.81) compared with diabetic individuals without DR. Evidences showed a higher risk of all-cause mortality associated with DR in patients with T2D or T1D (RR 2.25, 95% CI 1.91-2.65. RR 2.68, 95% CI 1.34-5.36). According to different grades of DR in patients with T2D, RR for all-cause mortality varied, the risk of nonproliferative diabetic retinopathy (NPDR) was 1.38 (1.11-1.70), while the risk of proliferative diabetic retinopathy (PDR) was 2.32 (1.75-3.06). There was no evidence of significant heterogeneity (Cochran Q test P=0.29 vs 0.26, I-2=19.6% vs 22.6%, respectively). Data from 5 studies in relation to DR and the risk of stroke showed that DR was significantly associated with increased risk of stroke (RR=1.74, 95% CI: 1.35-2.24), compared with patients without DR. Furthermore, DR (as compared with individuals without DR) was associated with a marginal increased risk of HF in patients with diabetes mellitus (DM) (n=3 studies; RR 2.24, 95% CI 0.98-5.14, P=0.056). Our results showed that DR increased the risk of all-cause mortality, regardless of the different stages, compared with the diabetic individuals without DR. DR predicted increased risk of stroke and HF. Although only 3 studies about HF were available, the association between DR and HF should be careful.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] Prognostic role of copeptin with all-cause mortality after heart failure: a systematic review and meta-analysis
    Zhang, Peng
    Wu, Xiaomei
    Li, Guangxiao
    Sun, Hao
    Shi, Jingpu
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2017, 13 : 49 - 58
  • [22] Associations of dietary patterns with the risk of all-cause, CVD and stroke mortality: a meta-analysis of prospective cohort studies
    Li, Fei
    Hou, Li-na
    Chen, Wei
    Chen, Peng-liang
    Lei, Chen-yong
    Wei, Qiang
    Tan, Wan-long
    Zheng, Shao-bin
    BRITISH JOURNAL OF NUTRITION, 2015, 113 (01) : 16 - 24
  • [23] Post-stroke epilepsy and risk of all-cause mortality: A systematic review and meta-analysis of cohort studies
    Ren, Zhong
    Wen, Quan
    Yan, Xue
    Wang, Ying
    Zhang, Yidan
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2022, 220
  • [24] Risk of All-Cause Mortality in Diabetic Patients Taking β-Blockers
    Tsujimoto, Tetsuro
    Kajio, Hiroshi
    Shapiro, Martin F.
    Sugiyama, Takehiro
    MAYO CLINIC PROCEEDINGS, 2018, 93 (04) : 409 - 418
  • [25] Uric acid is a risk factor for ischemic stroke and all-cause mortality in the general population: a gender specific analysis from The Tromso Study
    Storhaug, Hilde M.
    Norvik, Jon V.
    Toft, Ingrid
    Eriksen, Bjorn O.
    Lochen, Maja-Lisa
    Zykova, Svetlana
    Solbu, Marit
    White, Sarah
    Chadban, Steve
    Jenssen, Trond
    BMC CARDIOVASCULAR DISORDERS, 2013, 13
  • [26] Impact of a Nurse-Led Heart Failure Program on All-Cause Mortality
    Bdeir, Bassam
    Conboy, Tara
    Mukhtar, Abdulmajid
    Omer, Hafez
    Odeh, Raed
    Farah, Iyad
    Al-Khateeb, May
    Tayiem, Alaa
    Dosari, Alhanouf
    Al Mallah, Mouaz
    JOURNAL OF CARDIOVASCULAR NURSING, 2015, 30 (02) : E7 - E14
  • [27] Prognostic value of pupil area for all-cause mortality in patients with heart failure
    Nozaki, Kohei
    Hamazaki, Nobuaki
    Yamamoto, Shohei
    Kamiya, Kentaro
    Tanaka, Shinya
    Ichikawa, Takafumi
    Nakamura, Takeshi
    Yamashita, Masashi
    Maekawa, Emi
    Matsunaga, Atsuhiko
    Yamaoka-Tojo, Minako
    Ako, Junya
    ESC HEART FAILURE, 2020, 7 (05): : 3067 - 3074
  • [28] Associations of Heart Failure Onset Age with All-Cause Mortality: The Kailuan Study
    Li, Wei
    Gao, Haibo
    Zhao, Xuemei
    Wang, Yifei
    Yang, Jing
    Zheng, Hongwei
    Wang, Liyan
    Wu, Shouling
    Zhang, Qi
    CARDIOVASCULAR INNOVATIONS AND APPLICATIONS, 2024, 9 (01) : 1 - 9
  • [29] Cumulative Resting Heart Rate Exposure and Risk of All-Cause Mortality: Results from the Kailuan Cohort Study
    Zhao, Quanhui
    Li, Haibin
    Wang, Anxin
    Guo, Jin
    Yu, Junxing
    Luo, Yanxia
    Chen, Shuohua
    Tao, Lixin
    Li, Yuqing
    Li, Aiping
    Guo, Xiuhua
    Wu, Shouling
    SCIENTIFIC REPORTS, 2017, 7
  • [30] Vitamin D intake and risk of CVD and all-cause mortality: evidence from the Caerphilly Prospective Cohort Study
    Guo, Jing
    Cockcroft, John R.
    Elwood, Peter C.
    Pickering, Janet E.
    Lovegrove, Julie A.
    Givens, David I.
    PUBLIC HEALTH NUTRITION, 2017, 20 (15) : 2744 - 2753